The expense associated with Tumor-Infiltrating Lymphocyte (TIL) therapy for melanoma varies based on factors like geographic location and the healthcare facility offering the treatment. Specifically, in the United States, the cost for TIL therapy can range substantially, starting from around $250,000 and potentially escalating to $750,000. In contrast, Sheba Medical Center in Israel, known for providing this advanced melanoma treatment, offers it at a more competitive rate of $120,000 USD.
The quoted figures typically cover various components of the treatment process, including the extraction and cultivation of the TILs, the infusion process, and any necessary supportive care. It's crucial to remember that these costs are subject to change based on the specific needs of the patient, the treatment's complexity, and other relevant medical considerations.
What is TIL therapy for metastatic melanoma?
TIL immunotherapy for Melanoma in Israel >>
